Ritalin Linked to Possible Cancer Risk

According to a report in the Houston Chronicle, results from blood analysis of a small group of Ritalin users indicate a twofold to threefold increase in abnormal chromosome breaks which are associated with an increased risk of cancer.

Researchers affiliated with the University of Texas Medical Branch conducted the study. It's believed that the size of the study was too small to make any definitive statement concerning cancer risks with methylphenidate, the generic name for Ritalin. Future study is considered necessary.